Retinal Vein Occlusion and Diabetic Macular Oedema Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are older than 18 years of age
• People who have been diagnosed with either Type 1 or Type 2 Diabetes and have recently been diagnosed with a condition called Proliferative Diabetic Retinopathy (PDR), which is an advanced stage of diabetic eye disease
• People whose vision meets a minimum level of sharpness, measured on a standard eye chart (confirm with trial site for exact threshold)
• People whose retina (the light-sensitive layer at the back of the eye) measures less than 300 micrometres in thickness on a special scan called an OCT, with no fluid-filled pockets (cysts) present
• People whose eye is clear enough and whose pupil can be dilated wide enough to allow a type of laser eye treatment called PRP (Panretinal Photocoagulation)

Who may not be able to join:

• People who have had eye surgery in the past 4 months, or who have eye surgery planned within the next 3 months
• People who have had, or currently have, a condition where diabetic swelling affects the central part of the retina (called centre-involved diabetic macular oedema)
• People whose eye being studied has previously received PRP laser treatment, injections into the eye, or laser treatment to the central retina area
• People who are taking medications known to increase the risk of swelling in the retina
• People whose eye has cloudiness or other issues that would prevent the laser treatment from being delivered properly
• People whose general health makes it very difficult or impossible to receive laser treatment in a clinic setting

Important: Always verify eligibility with the trial site directly before applying.